SK Capital closes Perrigo API buy

SK Capital said Nov. 21 that completed its buy of Perrigo Co plc’s active pharmaceutical ingredients business. The deal was announced in August. The API unit was renamed Wavelength Pharmaceuticals.

DealsNorth AmericaUSBriefs